Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands

European Journal of Pharmacology

Volumn 425, Issue 1, 2001, Pages 73-83

  Smith, Sidney R ^a   Terminelli, Carol ^a   Denhardt, Georgetta ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

(Mouse); C. parvum; Cytokine; HU 210; SR141716A; SR144528; WIN 55212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR ANTAGONIST; CYTOKINE; DEXANABINOL; LIGAND; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG SELECTIVITY; ENDOTOXEMIA; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RECEPTOR INTRINSIC ACTIVITY;

ANIMALS; BORNANES; CANNABINOIDS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; ENDOTOXINS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-10; INTERLEUKIN-12; LIGANDS; MALE; MICE; MICE, KNOCKOUT; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PROPIONIBACTERIUM ACNES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SURVIVAL RATE; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE FACTORS, BORDETELLA;

EID: 0035800564     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01142-6     Document Type: Article

References (40)

1. Isolation and expression of a mouse CB1 receptor gene-comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells
2. Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation
3. Cloning and sequencing of a cDNA encoding the mouse brain type cannabinoid receptor protein
4. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A). Inhibition of delta 9-tetrahydrocannabinol-induced responses and agonist activity
5. Cannabinoid receptors and their endogenous agonists
6. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors
7. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
8. Molecular cloning of a human cannabinoid receptor which is also expressed in testis
9. s linkage to the CB1 receptor
10. Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals
11. Evaluation of the cannabioid CB2 receptor-selective antagonist SR144528: Further evidence for cannabinoid CB2 receptor absence in the rat central nervous system
12. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse
13. HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor
14. Intrathecal morphine in mice: A new technique
15. The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder
16. The cannabinoid system and cytokine network
17. 9-Tetrahydrocannabinol treatment suppresses immunity and early IFN-γ and IL-12 β2 responses to Legionella pneumophilia infection
18. Regulation of endotoxin-induced IL-6 production in liver sinusoidal endothelial cells and Kupffer cells by IL-10
19. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats
20. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors
21. Expression of CB2 cannabinoid receptor mRNA in adult rat retina
22. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
23. Molecular characterization of a peripheral receptor for cannabinoids
24. A role for central cannabinoid and opiod systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in mice
25. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
26. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
27. Biochemical and pharmacological characterization of SR141716A, the first potent and selective cannabinoid receptor antagonist
28. SR1442528, the first potent and selective antagonist of the CB2 cannabinoid receptor
29. 2-mediated supraspinal analgesia in mice
30. Role of liver NK cells and peritoneal macrophages in gamma interferon and interleukin-10 production in experimental bacterial peritonitis in mice
31. Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor
32. The ALIAmide palmitoylethanolamine and cannabinoids, but not anandamide are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons
33. The cooperative effects of TNF-α and IFN-γ are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia
34. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against endotoxin- and TNF-α-induced lethality
35. Endogenous mouse interleukin-10 is up-regulated by exogenously administered recombinant human interleukin-10, but does not contribute to the efficacy of the human protein in mouse models of endotoxemia
36. Effects of cannabinoid receptor agonist and antagonist ligands on the production of inflammatory cytokines and antiinflammatory IL-10
37. Pretreatment with pertussis toxin differentially modulates morphine- and β-endorphin-induced antinociception in the mouse
38. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
39. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: Possible mechanism for interaction with morphine
40. Increased mortality, hypoactivity, and hypoalgesia in cannabinoiod receptor knockout mice